Seoul
South Korea
6
2022-11-10
6
2026-04-07
These are the the leading inventors for applications assigned to STCUBE & CO., INC.:
STCUBE & CO., INC. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
ANTIBODIES SPECIFIC TO GLYCOSYLATED LAG3 AND METHODS OF USE THEREOF
#2 | 2021-05-20 ✅ Patent 11,970,534 granted on 2024-04-30Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof
#3 | 2020-04-30 ✅ Patent 11,542,331 granted on 2023-01-03Methods of treating cancer using antibodies and molecules that bind to BTN1A1 or BTN1A1-ligands
#4 | 2020-04-30 ✅ Patent 12,215,151 granted on 2025-02-04Methods of treating cancer using antibodies and molecules that immunospecifically bind to BTN1A1
#5 | 2019-04-11 ✅ Patent 12,059,474 granted on 2024-08-13Methods for selecting antibodies that specifically bind glycosylated immune checkpoint proteins
#6 | 2018-12-13 ✅ Patent 10,875,920 granted on 2020-12-29Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof
Also check out STCUBE & CO., INC.'s (Seoul, South Korea) applicant profile with 10 patent applications submitted.
354245 ⎘